Shaun J Kilty Selected Research

Gelatin

1/2014

Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaun J Kilty Research Topics

Disease

5	Rhinosinusitis 04/2022 - 03/2008
4	Epistaxis (Nosebleed) 12/2019 - 01/2014
1	Nasal Polyps (Nasal Polyp) 04/2022
1	Polyps 04/2022
1	Granuloma 03/2019
1	Sensorineural Hearing Loss 03/2019
1	Hearing Loss (Hearing Impairment) 03/2019
1	Laryngopharyngeal Reflux 01/2017
1	Neoplasms (Cancer) 08/2013
1	Postoperative Pain 06/2013
1	Infections 02/2011
1	Sinusitis 12/2008

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 04/2022 - 11/2015
1	dupilumabIBA 04/2022
1	Petrolatum (Vaseline)FDA Link 12/2019
1	Silver NitrateIBA 12/2019
1	CholesterolIBA 03/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2018
1	Proton Pump InhibitorsIBA 01/2017
1	IronIBA 12/2015
1	anti-IgE antibodiesIBA 11/2015
1	Thrombin FDA Link 01/2014
1	GelatinIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	SteroidsIBA 03/2008

Therapy/Procedure

7	Therapeutics 04/2022 - 03/2008
1	Surgical Instruments (Clip) 12/2019
1	Cautery 12/2019
1	FloSeal Matrix 01/2018
1	Blood Transfusion (Blood Transfusions) 12/2015
1	Aftercare (After-Treatment) 01/2014
1	Radiotherapy 08/2013
1	Splints (Splint) 06/2013
1	Sutures (Suture) 06/2013